Clinical trial
A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
NCT00364260 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00364260 |
|---|---|
| Title | A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. |
| Official title | A Study to Determine the Impact of Hemoglobin Maintenance and Other Interventional Strategies to Prevent or Delay the Progression of Left Ventricular Mass Growth in Subjects With Early Renal Insufficiency. |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Kidney Failure, Left Ventricular Hypertrophy |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 172 |
| Start date | Dec 1, 1997 |
| Completion | Aug 1, 2003 |
| First posted | Aug 15, 2006 |
| Last update posted | Feb 1, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: